Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 3 (2006), Issue 10 (October)

1. Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.
   Neuron, 52(1): 15-31. [Abstract] [Full-text]
2. A hundred years of Alzheimer's disease research.
   Neuron, 52(1): 3-13. [Abstract] [Full-text]
3. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
   FEBS Lett, 580(23): 5525-32. [Abstract] [Full-text]
4. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.
   J Neurosci, 26(40): 10222-31. [Abstract] [Full-text]
5. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
   J Neurosci, 26(40): 10129-40. [Abstract] [Full-text]
6. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
   J Neuropathol Exp Neurol, 65(10): 1012-21. [Abstract] [Full-text]
7. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
   J Neuropathol Exp Neurol, 65(10): 976-87. [Abstract] [Full-text]
8. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.
   Neurology, 67(7): 1215-20. [Abstract] [Full-text]
9. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
   N Engl J Med, 355(15): 1525-38. [Abstract] [Full-text]
10. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.
    J Neurol Neurosurg Psychiatry, 77(11): 1219-22. [Abstract] [Full-text]
11. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse.
    Biochem Biophys Res Commun, 350(3): 530-6. [Abstract] [Full-text]
12. Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.
    J Neurosci, 26(42): 10636-45. [Abstract] [Full-text]
13. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Neurochem Int, 49(7): 631-9. [Abstract] [Full-text]
14. Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan.
    Neurobiol Aging, 27(12): 1797-806. [Abstract] [Full-text]
15. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
    Neurobiol Aging, 27(12): 1763-8. [Abstract] [Full-text]
16. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
    Neurobiol Aging, 27(12): 1769-85. [Abstract] [Full-text]
17. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease.
    Neurobiol Aging, 27(12): 1757-62. [Abstract] [Full-text]
18. Relationship of vascular risk to the progression of Alzheimer disease.
    Neurology, 67(8): 1357-62. [Abstract] [Full-text]
19. Aging of the brain, entropy, and Alzheimer disease.
    Neurology, 67(8): 1340-52. [Abstract] [Full-text]
20. Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications.
    Interdiscip Top Gerontol, 35: 159-75. [Abstract] [Full-text]
21. Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications.
    Prog Neuropsychopharmacol Biol Psychiatry, 30(8): 1369-80. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.